12x
7 minutes ago
Here is the ChatGPT's Blarcamesine long-term efficacy calculation using the leaked AD/PD 2025 presentation:
The long-term disease-modifying & sustained efficacy seems to be 45% vs 27% slowing, 2x better than Lecanemab, at least for the (super) responders, potentially double the patient's rema